Literature DB >> 10022915

The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation.

J Kim1, D Prawitt, N Bardeesy, E Torban, C Vicaner, P Goodyer, B Zabel, J Pelletier.   

Abstract

Gonadal differentiation is dependent upon a molecular cascade responsible for ovarian or testicular development from the bipotential gonadal ridge. Genetic analysis has implicated a number of gene products essential for this process, which include Sry, WT1, SF-1, and DAX-1. We have sought to better define the role of WT1 in this process by identifying downstream targets of WT1 during normal gonadal development. We have noticed that in the developing murine gonadal ridge, wt1 expression precedes expression of Dax-1, a nuclear receptor gene. We document here that the spatial distribution profiles of both proteins in the developing gonad overlap. We also demonstrate that WT1 can activate the Dax-1 promoter. Footprinting analysis, transient transfections, promoter mutagenesis, and mobility shift assays suggest that WT1 regulates Dax-1 via GC-rich binding sites found upstream of the Dax-1 TATA box. We show that two WT1-interacting proteins, the product of a Denys-Drash syndrome allele of wt1 and prostate apoptosis response-4 protein, inhibit WT1-mediated transactivation of Dax-1. In addition, we demonstrate that WT1 can activate the endogenous Dax-1 promoter. Our results indicate that the WT1-DAX-1 pathway is an early event in the process of mammalian sex determination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022915      PMCID: PMC84021          DOI: 10.1128/MCB.19.3.2289

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.

Authors:  W H Shen; C C Moore; Y Ikeda; K L Parker; H A Ingraham
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

2.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene.

Authors:  J W Foster; M A Dominguez-Steglich; S Guioli; C Kwok; P A Weller; M Stevanović; J Weissenbach; S Mansour; I D Young; P N Goodfellow
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

3.  Male-to-female sex reversal in M33 mutant mice.

Authors:  Y Katoh-Fukui; R Tsuchiya; T Shiroishi; Y Nakahara; N Hashimoto; K Noguchi; T Higashinakagawa
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

4.  Müllerian-inhibiting substance function during mammalian sexual development.

Authors:  R R Behringer; M J Finegold; R L Cate
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

5.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9.

Authors:  T Wagner; J Wirth; J Meyer; B Zabel; M Held; J Zimmer; J Pasantes; F D Bricarelli; J Keutel; E Hustert; U Wolf; N Tommerup; W Schempp; G Scherer
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

6.  Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.

Authors:  H Nakagama; G Heinrich; J Pelletier; D E Housman
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

7.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

8.  A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal.

Authors:  B Bardoni; E Zanaria; S Guioli; G Floridia; K C Worley; G Tonini; E Ferrante; G Chiumello; E R McCabe; M Fraccaro
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

9.  An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita.

Authors:  E Zanaria; F Muscatelli; B Bardoni; T M Strom; S Guioli; W Guo; E Lalli; C Moser; A P Walker; E R McCabe
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

10.  Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism.

Authors:  F Muscatelli; T M Strom; A P Walker; E Zanaria; D Récan; A Meindl; B Bardoni; S Guioli; G Zehetner; W Rabl
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

View more
  23 in total

Review 1.  Genetics of the development and function of the adrenal cortex.

Authors:  K L Parker; B P Schimmer
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Wilms' tumor gene WT1: its oncogenic function and clinical application.

Authors:  H Sugiyama
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Sex determination in the Squalius alburnoides complex: an initial characterization of sex cascade elements in the context of a hybrid polyploid genome.

Authors:  Irene Pala; Manfred Schartl; Sólveig Thorsteinsdóttir; Maria Manuela Coelho
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

4.  Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.

Authors:  Takuya Osada; Christopher Y Woo; Matthew McKinney; Xiao Yi Yang; Gangjun Lei; Heather G Labreche; Zachary C Hartman; Donna Niedzwiecki; Nelson Chao; Andrea Amalfitano; Michael A Morse; H Kim Lyerly; Timothy M Clay
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

5.  The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.

Authors:  Dagmar Wilhelm; Christoph Englert
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

6.  The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy.

Authors:  Lesley A Simpson; Emily A Burwell; Kida A Thompson; Samira Shahnaz; Allen R Chen; David M Loeb
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

7.  Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.

Authors:  Claudia Andreu-Vieyra; Ruihong Chen; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-07-03

Review 8.  Regulation of gene expression by WT1 in development and tumorigenesis.

Authors:  Leif W Ellisen
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 9.  The role of WT1 in oncogenesis: tumor suppressor or oncogene?

Authors:  David M Loeb; Saraswati Sukumar
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 10.  Cancer immunotherapy targeting WT1 protein.

Authors:  Haruo Sugiyama
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.